Perugia, Italy

Nunzio Iraci


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nunzio Iraci: Innovator in Neurodegenerative Disorder Treatments

Introduction

Nunzio Iraci is a notable inventor based in Perugia, Italy. He has made significant contributions to the field of neurodegenerative disorders through his innovative research and patenting efforts. His work focuses on therapeutic agents that target protein aggregation, a key factor in many neurodegenerative diseases.

Latest Patents

Nunzio Iraci holds a patent for "Prion protein ligands as therapeutic agents for neurodegenerative disorders." This invention provides compositions and methods for treating neurodegenerative diseases, particularly those associated with protein aggregation. The patent is based on the discovery of binding regions on the surface of PrPc, known as PrPc Binding Domains (PBD). The inventor has identified six distinct binding regions on PrPc, referred to as PBD-1 through PBD-6. These domains are defined by clusters of amino acids located in the globular domain of the protein, specifically in the C-terminal half of the protein, with one embodiment utilizing residues 127-226.

Career Highlights

Throughout his career, Nunzio Iraci has worked with prestigious institutions, including Boston University and Università di Perugia. His research has contributed to a deeper understanding of neurodegenerative disorders and has the potential to lead to new therapeutic approaches.

Collaborations

Nunzio has collaborated with notable colleagues such as Emiliano Biasini and David A. Harris. Their combined expertise has further advanced the research in the field of neurodegenerative diseases.

Conclusion

Nunzio Iraci's innovative work in the treatment of neurodegenerative disorders highlights the importance of research in developing effective therapies. His contributions through patents and collaborations continue to pave the way for advancements in this critical area of health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…